Drug intelligence / Profile preview

maslinic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Maslinic acid is a **pentacyclic triterpene** (oleanane series) primarily found in the skin and waxy coating of olives (Olea europaea) and other plants. Mechanistically, it exhibits **antioxidant**, **anti-inflammatory**, **antitumor/antineoplastic**, **antidiabetic/hypoglycemic**, **cardioprotective**, **neuroprotective**, and **antimicrobial** effects. It inhibits serine proteases (linked to antiviral activity), suppresses proinflammatory cytokines (e.g., TNF-α, IL-6), promotes glutamate reuptake by upregulating the glial transporter EAAT2 (GLT-1), and inhibits glycogen phosphorylase, contributing to hypoglycemic effects. Maslinic acid induces apoptosis in cancer cells, modulates oxidative stress, and influences metabolic enzyme activity, including those involved in lipogenesis and lipolysis. It is under evaluation for roles in cardiovascular disease prevention, diabetes, nonalcoholic fatty liver disease, cancer, and muscle wasting in the elderly. Often used as a **dietary supplement** or cosmetic ingredient, it is regarded as safe at relevant doses and has not been associated with substantial toxicity in animal studies[1][2][3][4][5][6][7][9].

Other names
maslinic acidcrategolic acidmaslic acidcrataegolic acid2alpha-hydroxyoleanolic acid(2alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid
02

Targets

SLC1A2 (Glutamate Transporter 1)PYG (Glycogen phosphorylase)HSF1 (Heat shock factor protein 1)Parasitic serine proteaseNF-κBF2 (Thrombin)

Beyond the preview

Go deeper on maslinic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on maslinic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call